What Is a Synthetic Data Business Worth?

The core valuation question for a synthetic-data business is not whether it can generate data — most competent teams can build something that produces plausible-looking output. It is whether the business can actually prove that output is both useful enough for a customer to rely on and safe enough that it does not quietly leak the real data it was built from. That proof, or the absence of it, does more to separate a strong business from a fragile one in this sub-sector than any other single factor a buyer looks at.

What a buyer is actually paying for

A buyer is paying for proprietary generation methods or simulation environments that produce measurably higher-fidelity data than generic tools available to anyone, and for enterprise customers in regulated sectors — health, finance — who are buying the product to solve a real compliance problem rather than to experiment with a novelty. Fidelity and utility metrics that a customer can independently verify, rather than take on faith, are worth materially more than an internal benchmark the company alone controls, because independent verification is exactly what a buyer’s own due diligence will demand later anyway. And recurring, subscription-based access to a generation platform is worth a different multiple than one-off dataset delivery, because it signals customers who keep coming back to solve an ongoing problem rather than a one-time need the business happened to fill once.

What gets discounted, and why

• Generation models trained on real client or third-party data with no licence permitting that use are not merely a compliance gap — they are a live question over whether the business actually owns the core technology it is selling.
• No clear documentation of how synthetic the output actually is exposes real re-identification risk if source data leaks through the generation process, and a buyer has no way to price that risk without the documentation.
• Heavy dependence on a single upstream foundation model for generation makes the business’s entire product vulnerable to a pricing or access decision made by a company it does not control.
• Compute-intensive generation runs that make per-dataset cost highly variable compress margin unpredictably as the customer base grows, unlike a business whose costs scale in a predictable line with revenue.

How the earnings actually get recast

Compute cost is a real, scaling cost of goods sold, not a fixed overhead line, and treating it as fixed produces a normalized earnings figure that will not hold up once a buyer models the business at a higher volume of dataset generation. One-off custom-dataset delivery fees are project revenue and need to be separated from recurring platform-access revenue, since a buyer is paying a meaningfully different multiple for the two. Owner compensation and one-time model-development costs get added back the way they would in any recast, and where the business has claimed research and development tax credits on its generation-model work, a buyer’s advisor will want to see how that funding affected reported development costs before relying on the earnings figure that results.

Why two similar-looking synthetic-data businesses price differently

One company has published, third-party-verifiable fidelity benchmarks and a handful of anchor customers in regulated sectors who renew every year because the product genuinely solves a compliance problem for them. The other is a general-purpose tabular-data generator with no independent verification of its output, uncertain sourcing behind its own training data, and a customer base that churns because the product is easy to substitute. Both might report similar revenue today. The first is worth meaningfully more, because a buyer is paying for demonstrated trust and switching costs that are hard for a new entrant to replicate quickly, not simply for the technology’s existence.

What actually determines the number

Mechanism explains why one synthetic-data business commands a stronger multiple than a comparable one; it does not produce a number, and any figure discussed in general content like this is illustrative industry discussion only, never an appraisal of a specific business. A Chartered Business Valuator or another qualified valuation professional applies recognized methods to the company’s actual financials, customer contracts and risk profile, and should specifically confirm how any re-identification testing evidence, or the lack of it, affects the risk adjustment applied to the earnings base.